ARTICLE | Clinical News
Interleukin-2 diphtheria fusion toxin: Ended a Phase II trial
January 2, 1996 8:00 AM UTC
Doses were 5, 10 , and 15 µg/kg/day for three days, for a total of four weeks, whereas a prior psoriasis trial used 2, 4, 6, and 9 µg/kg/day for five days each month. A total of 382 patients have received the agent to date. ...